Abstract
Suspicion of papilledema or swelling of the optic nerves from elevated intracranial pressure (ICP) is a common reason for referral to pediatric neuro-ophthalmology. The pediatric neuro-ophthalmologist is tasked with confirming the presence or absence of papilledema and if present, determining the next steps in evaluation and management. Increased ICP, in the absence of a mass, has been labeled pseudotumor cerebri syndrome [1–4]. This designation encompasses idiopathic intracranial hypertension (IIH; used interchangeably with primary pseudotumor cerebri syndrome in this chapter) as well as elevated ICP secondary to etiologies including exposure to certain medications, in association with underlying systemic disease, and cerebral venous system abnormalities. This chapter outlines the epidemiology, pathophysiology, and etiologies of pseudotumor cerebri syndrome (PTCS). Further, this chapter reviews the most recent diagnostic criteria, disease monitoring methods, treatment approaches, and visual outcomes for PTCS. Having a systematic strategy in place to evaluate patients with papilledema and presumed pseudotumor cerebri is crucial for the timely identification of an underlying etiology, if present, and for the prevention of visual loss with effective treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65.
Beres SJ, Digre KB, Friedman DI, Liu GT. Pseudotumor cerebri syndrome is the best term for this condition. Pediatr Neurol. 2018;87:9–10.
Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–100.
Aylward SC, Waslo CS, Au JN, Tanne E. Manifestations of pediatric intracranial hypertension from the intracranial hypertension registry. Pediatr Neurol. 2016;61:76–82.
Gillson N, Jones C, Reem RE, Rogers DL, Zumberge N, Aylward SC. Incidence and demographics of pediatric intracranial hypertension. Pediatr Neurol. 2017;73:42–7.
Gordon K. Pediatric pseudotumor cerebri: descriptive epidemiology. Can J Neurol Sci. 1997;24(3):219–21.
Matthews YY, Dean F, Lim MJ, et al. Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child. 2017;102(8):715–21.
Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875–7.
Tepe D, Demirel F, Seker ED, et al. Prevalence of idiopathic intracranial hypertension and associated factors in obese children and adolescents. J Pediatr Endocrinol Metab. 2016;29(8):907–14.
Sheldon CA, Paley GL, **ao R, et al. Pediatric idiopathic intracranial hypertension: age, gender, and anthropometric features at diagnosis in a large, retrospective. Multisite Cohort Ophthalmol. 2016;123(11):2424–31.
Glatstein MM, Oren A, Amarilyio G, et al. Clinical characterization of idiopathic intracranial hypertension in children presenting to the emergency department: the experience of a large tertiary care pediatric hospital. Pediatr Emerg Care. 2015;31(1):6–9.
Balcer LJ, Liu GT, Forman S, et al. Idiopathic intracranial hypertension: relation of age and obesity in children. Neurology. 1999;52(4):870–2.
Brara SM, Koebnick C, Porter AH, Langer-Gould A. Pediatric idiopathic intracranial hypertension and extreme childhood obesity. J Pediatr. 2012;161(4):602–7.
Shah V, Hoyos-Martinez A, Horne VE. Association of adrenal insufficiency with pediatric Pseudotumor cerebri syndrome. JAMA Ophthalmol. 2020;138(11):1187–91.
Beres SJ. Update in Pediatric Pseudotumor Cerebri Syndrome. Semin Neurol. 2020;40(3):286–93.
Sheldon CA, Kwon YJ, Liu GT, McCormack SE. An integrated mechanism of pediatric pseudotumor cerebri syndrome: evidence of bioenergetic and hormonal regulation of cerebrospinal fluid dynamics. Pediatr Res. 2015;77(2):282–9.
Kesler A, Fattal-Valevski A. Idiopathic intracranial hypertension in the pediatric population. J Child Neurol. 2002;17(10):745–8.
Aylward SC, Aronowitz C, Reem R, Rogers D, Roach ES. Intracranial hypertension without headache in children. J Child Neurol. 2015;30(6):703–6.
Bassan H, Berkner L, Stolovitch C, Kesler A. Asymptomatic idiopathic intracranial hypertension in children. Acta Neurol Scand. 2008;118(4):251–5.
Whitecross S, Heidary G. Asymptomatic pediatric idiopathic intracranial hypertension. J AAPOS. 2013;17(01):e31.
Orme DR, Vegunta S, Miller MA, et al. A comparison between the clinical features of Pseudotumor cerebri secondary to tetracyclines and idiopathic intracranial hypertension. Am J Ophthalmol. 2020;220:177–82.
Liu KC, Bhatti MT, Chen JJ, et al. Presentation and progression of papilledema in cerebral venous sinus thrombosis. Am J Ophthalmol. 2020;213:1–8.
Thambisetty M, Lavin PJ, Newman NJ, Biousse V. Fulminant idiopathic intracranial hypertension. Neurology. 2007;68(3):229–32.
Aylward SC, Aronowitz C, Roach ES. Intracranial hypertension without papilledema in children. J Child Neurol. 2016;31(2):177–83.
Sibony PA, Kupersmith MJ, Kardon RH. Optical coherence tomography Neuro-toolbox for the diagnosis and Management of Papilledema, optic disc edema, and Pseudopapilledema. J Neuroophthalmol. 2021;41(1):77–92.
Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol. 2002;47(6):515–32.
Friedman AH, Gartner S, Modi SS. Drusen of the optic disc. A retrospective study in cadaver eyes. Br J Ophthalmol. 1975;59(8):413–21.
Malmqvist L, Li XQ, Eckmann CL, et al. Optic disc Drusen in children: the Copenhagen child cohort 2000 eye study. J Neuroophthalmol. 2018;38(2):140–6.
Malmqvist L, Bursztyn L, Costello F, et al. The optic disc Drusen studies consortium recommendations for diagnosis of optic disc Drusen using optical coherence tomography. J Neuroophthalmol. 2018;38(3):299–307.
Chang MY, Velez FG, Demer JL, et al. Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus Pseudopapilledema. Ophthalmology. 2017;124(12):1839–48.
Merchant KY, Su D, Park SC, et al. Enhanced depth imaging optical coherence tomography of optic nerve head drusen. Ophthalmology. 2013;120(7):1409–14.
Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106(4):492–513.
Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5(1):55–6.
Wall M, Kupersmith MJ, Kieburtz KD, et al. The idiopathic intracranial hypertension treatment trial: clinical profile at baseline. JAMA Neurol. 2014;71(6):693–701.
Kohli AA, Vossough A, Mallery RM, et al. Magnetic resonance imaging findings in pediatric Pseudotumor cerebri syndrome. Pediatr Neurol. 2019;99:31–9.
Hartmann AJ, Soares BP, Bruce BB, et al. Imaging features of idiopathic intracranial hypertension in children. J Child Neurol. 2017;32(1):120–6.
Gilbert AL, Vaughn J, Whitecross S, Robson CD, Zurakowski D, Heidary G. Magnetic resonance imaging features and clinical findings in pediatric idiopathic intracranial hypertension: a case-control study. Life (Basel). 2021;11(6):487.
Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB, International Society for Magnetic Resonance in M. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16(7):564–70.
Hollander JPS, Heidary G. Utilization of MRV to evaluate pediatric patients with papilledema. J AAPOS. 2014;18(04):2.
Gerstl L, Schoppe N, Albers L, et al. Pediatric idiopathic intracranial hypertension - is the fixed threshold value of elevated LP opening pressure set too high? Eur J Paediatr Neurol. 2017;21(6):833–41.
Masri A, Jaafar A, Noman R, Gharaibeh A, Ababneh OH. Intracranial hypertension in children: etiologies, clinical features, and outcome. J Child Neurol. 2015;30(12):1562–8.
Delaney AC, Velarde A, Harper MB, et al. Predictors of primary intracranial hypertension in children using a newly suggested opening pressure cutoff of 280 mm H2O. Pediatr Neurol. 2019;91:27–33.
Beres SJ, Sheldon CA, Boisvert CJ, et al. Clinical and prognostic significance of cerebrospinal fluid opening and closing pressures in pediatric Pseudotumor cerebri syndrome. Pediatr Neurol. 2018;83:50–5.
Committee NIIHSGW, Wall M, McDermott MP, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311(16):1641–51.
Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7.
Jion YI, Raff A, Grosberg BM, Evans RW. The risk and management of kidney stones from the use of topiramate and zonisamide in migraine and idiopathic intracranial hypertension. Headache. 2015;55(1):161–6.
Gaier ED, Heidary G. Pediatric idiopathic intracranial hypertension. Semin Neurol. 2019;39(6):704–10.
Liu GT, Glaser JS, Schatz NJ. High-dose methylprednisolone and acetazolamide for visual loss in pseudotumor cerebri. Am J Ophthalmol. 1994;118(1):88–96.
Tovia E, Reif S, Oren A, Mitelpunkt A, Fattal-Valevski A. Treatment response in pediatric patients with Pseudotumor cerebri syndrome. J Neuroophthalmol. 2017;37(4):393–7.
Thuente DD, Buckley EG. Pediatric optic nerve sheath decompression. Ophthalmology. 2005;112(4):724–7.
Hanak BW, Bonow RH, Harris CA, Browd SR. Cerebrospinal fluid shunting complications in children. Pediatr Neurosurg. 2017;52(6):381–400.
Brune AJ, Girgla T, Trobe JD. Complications of ventriculoperitoneal shunt for idiopathic intracranial hypertension: a single-institution study of 32 patients. J Neuroophthalmol. 2021;41(2):224–32.
Jiramongkolchai K, Buckley EG, Bhatti MT, et al. Temporary lumbar drain as treatment for pediatric fulminant idiopathic intracranial hypertension. J Neuroophthalmol. 2017;37(2):126–32.
Ploof J, Aylward SC, Jordan CO, Drapeau AI. Case series of rapid surgical interventions in fulminant intracranial hypertension. J Child Neurol. 2021;36(11):1047–53.
Carter LM, Chakraborty AR, McCoy-Stephens TM, Strickland AE, Bohnstedt BN, Gross NL. Venous sinus stenosis treatment in pediatric idiopathic intracranial hypertension: illustrative case and literature review. World Neurosurg. 2021;149:2–7.
Dwyer CM, Prelog K, Owler BK. The role of venous sinus outflow obstruction in pediatric idiopathic intracranial hypertension. J Neurosurg Pediatr. 2013;11(2):144–9.
Ahmed RM, Zmudzki F, Parker GD, Owler BK, Halmagyi GM. Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting. AJNR Am J Neuroradiol. 2014;35(5):952–8.
Schwarz J, Al Balushi A, Sundararajan S, et al. Management of idiopathic intracranial hypertension in children utilizing venous sinus stenting. Interv Neuroradiol. 2021;27(2):257–65.
Wan MJ, Adebona O, Benson LA, Gorman MP, Heidary G. Visual outcomes in pediatric optic neuritis. Am J Ophthalmol. 2014;158(3):503–7 e2.
Group OCTS-SCfNIIHS, Auinger P, Durbin M, et al. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci. 2014;55(12):8180–8.
Optical Coherence Tomography Substudy C, Group NIIHS. Papilledema outcomes from the optical coherence tomography substudy of the idiopathic intracranial hypertension treatment trial. Ophthalmology. 2015;122(9):1939–45 e2.
Dreesbach M, Joachimsen L, Kuchlin S, et al. Optic nerve head volumetry by optical coherence tomography in papilledema related to idiopathic intracranial hypertension. Transl Vis Sci Technol. 2020;9(3):24.
Group OCTS-SCfNIIHS, Auinger P, Durbin M, et al. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features. Invest Ophthalmol Vis Sci. 2014;55(12):8173–9.
Lessell S, Rosman NP. Permanent visual impairment in childhood pseudotumor cerebri. Arch Neurol. 1986;43(8):801–4.
Stiebel-Kalish H, Kalish Y, Lusky M, Gaton DD, Ehrlich R, Shuper A. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension. Am J Ophthalmol. 2006;142(2):279–83.
Soiberman U, Stolovitch C, Balcer LJ, Regenbogen M, Constantini S, Kesler A. Idiopathic intracranial hypertension in children: visual outcome and risk of recurrence. Childs Nerv Syst. 2011;27(11):1913–8.
Gospe SM 3rd, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100(4):505–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Gise, R., Gaier, E.D., Heidary, G. (2022). Pseudotumor Cerebri Syndrome in Children: Current Diagnosis and Treatment. In: Ramasubramanian, A. (eds) Pediatric Ophthalmology. Current Practices in Ophthalmology. Springer, Singapore. https://doi.org/10.1007/978-981-19-4963-0_9
Download citation
DOI: https://doi.org/10.1007/978-981-19-4963-0_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-19-4962-3
Online ISBN: 978-981-19-4963-0
eBook Packages: MedicineMedicine (R0)